Convergent evolution of two different random RNAs for specific interaction with methionyl-tRNA synthetase.

Biochem Biophys Res Commun

Center for Medicinal Protein Network and Systems Biology, Seoul National University, Seoul 151-742, Republic of Korea.

Published: March 2013

Aminoacyl-tRNA synthetases (ARSs) recognize a specific sequence or structural characteristics of their cognate tRNAs. To contribute to the understanding how these recognition sites were selected, we generated two different RNA libraries containing either 42mer or 70mer random sequence and used them to select RNA aptamers that specifically bound to methionyl-tRNA synthetase (MRS) of Mycobacterium tuberculosis. The aptamer pools selected from the two RNA libraries showed strong binding affinity and selectivity to M. tuberculosis MRS compared to that of the homologous Escherichia coli MRS. The RNA aptamers selected from the two completely unrelated RNA pools shared the octamer sequence including CAU and the anticodon sequence of tRNA(Met). The secondary structure prediction suggested that the octamer motif in the selected aptamers would form a loop similar to the anticodon loop of tRNA(Met). The results suggest that the RNA loop containing CAU triplet could selected as a major recognition site for MRS during evolution more or less regarding, and also showed that species-specific ARS inhibitors can be obtained by in vitro evolution.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2013.01.116DOI Listing

Publication Analysis

Top Keywords

methionyl-trna synthetase
8
rna libraries
8
rna aptamers
8
rna
6
selected
5
convergent evolution
4
evolution random
4
random rnas
4
rnas specific
4
specific interaction
4

Similar Publications

A novel methionyl-tRNA synthetase inhibitor targeting gram-positive bacterial pathogens.

Antimicrob Agents Chemother

December 2024

Center for Emerging and Re-emerging Infectious Diseases, Department of Medicine, Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington, USA.

New antibiotics are needed to treat gram-positive bacterial pathogens. is a novel inhibitor of methionyl-tRNA synthetase with selective activity against gram-positive bacteria. The minimum inhibitory concentrations (MICs) against and species range from 0.

View Article and Find Full Text PDF
Article Synopsis
  • - Brucellosis, caused by the Brucella bacterium, leads to serious economic losses in livestock due to reproductive issues and reduced milk production, coupled with antibiotic resistance complicating treatment efforts.
  • - This study focuses on isolating a compound called piperolactam A from Piper betle leaves, aiming to evaluate its potential as an antibacterial agent against Brucella sp. and its mechanism of action against specific enzymes in bacteria.
  • - Through molecular docking methods, the research shows that piperolactam A exhibits strong binding affinity to leucyl-tRNA synthetase (LeuRS), suggesting it could effectively inhibit bacterial growth by disrupting protein synthesis.
View Article and Find Full Text PDF

Light-Activatable, Cell-Type Specific Labeling of the Nascent Proteome.

ACS Chem Neurosci

October 2024

Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.

Elucidating the mechanisms by which protein synthesis contributes to complex biological processes has remained a challenging endeavor. This is particularly true in the field of neuroscience, where multiple, tightly regulated periods of new protein synthesis in different cell-types are thought to facilitate intricate neurological functions, such as memory formation. Current methods for labeling the proteome have lacked the spatial and temporal resolution to accurately discriminate these overlapping and often competing windows of mRNA translation.

View Article and Find Full Text PDF

Parkinson's disease is a progressive neurodegenerative disorder marked by the death of dopaminergic neurons in the substantia nigra region of the brain. Aggregation of alpha-synuclein (α-synuclein) is a contributing factor to Parkinson's disease pathogenesis. The objective of this study is to investigate the neuroprotective effects of gut microbes on α-synuclein aggregation using both in silico and in vivo approaches.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!